A Versatile Tumor Microenvironment-Responsive Nanoprobe for Cancer Screening and Early Detection.
A tumor microenvironment-responsive nanoprobe, PR-KAd@CD-AuNC, enabling cross-validated cancer detection through in vivo second near-infrared (NIR-II) fluorescence imaging and in vitro colorimetric urinalysis was employed to dynamically assess cancer therapeutic efficacy, suggesting clinical value for guiding treatment...